Assertio Holdings, Inc.
ASRT • NASDAQ
Assertio Holdings, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Mark L. Reisenauer, with a market cap of $125.0M.
CEOMark L. Reisenauer
Market Cap$125.0M
Drug Manufacturers - Specialty & Generic
Healthcare
Employees30.0
Websiteassertiotx.com
Next Earnings
Upcoming earnings announcement for Assertio Holdings, Inc.
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.31
Revenue Estimate
$10.9M
Earnings History
Past 12 earnings reports for Assertio Holdings, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Q4 2025 | -$1.06Est: -$2.30 | +53.9% | $13.5MEst: $5.6M | +141.0% |  10-K |
| Nov 10, 2025 | Q3 2025 | $0.18Est: -$0.03 | +700.0% | $49.5MEst: $27.0M | +83.4% | 10-Q |
| Aug 11, 2025 | Q2 2025 | $0.02Est: -$0.04 | +150.0% | $29.2MEst: $28.0M | +4.5% | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.04Est: -$0.06 | +33.3% | $26.5MEst: $28.0M | -5.2% | 10-Q |
| Mar 12, 2025 | Q4 2024 | -$0.03Est: -$0.04 | +25.0% | $32.2MEst: $29.9M | +7.5% | 10-K |
| Nov 11, 2024 | Q3 2024 | $0.03Est: -$0.05 | +160.0% | $29.2MEst: $28.9M | +1.2% | 10-Q |
| Aug 7, 2024 | Q2 2024 | $0.02Est: -$0.03 | +166.7% | $31.1MEst: $30.2M | +3.1% | 10-Q |
| May 6, 2024 | Q1 2024 | $0.04Est: -$0.03 | +233.3% | $32.4MEst: $29.5M | +10.0% | 10-Q |
| Mar 11, 2024 | Q4 2023 | $0.11Est: -$0.02 | +650.0% | $33.0MEst: $33.8M | -2.4% | 10-K |
| Nov 8, 2023 | Q3 2023 | $0.01Est: $0.11 | -90.9% | $35.6MEst: $53.1M | -32.9% | — |
| Aug 3, 2023 | Q2 2023 | $0.19Est: $0.14 | +35.7% | $41.0MEst: $39.6M | +3.6% | 10-Q |
| May 9, 2023 | Q1 2023 | $0.29Est: $0.13 | +123.1% | $42.5MEst: $37.6M | +12.8% | — |